treatment group:sirolimus

2 trials

Sponsors

The First Affiliated Hospital of China Medical University, Peking University First Hospital

Conditions

Systemic Sclerosislupus nephritis

Early Phase 1

The efficacy and safety of sirolimus for the treatment of Systemic Sclerosis: a single-arm, single-center pilot study

RecruitingChiCTR2000030370

The First Affiliated Hospital of China Medical UniversitySystemic Sclerosis

Start: 2020-03-01Updated: 2020-03-02

Phase 4

Open multicenter clinical study of sirolimus therapy combined glucocorticoid and immunosuppressant in active lupus nephritis with interstitial lesions

RecruitingChiCTR2600124863

Peking University First Hospitallupus nephritis

Start: 2022-07-18Updated: 2026-05-25